Search filters

List of works by Christophe Hézode

A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3.

scientific article published on 19 August 2016

Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

scientific article

Analysis of Ribavirin Mutagenicity in Human Hepatitis C Virus Infection

scientific article (publication date: July 2007)

Antiviral strategies in hepatitis C virus infection

scientific article

Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection

scientific article published on 4 June 2014

Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice ⬇️

scientific article published on February 1, 2012

Characterization of V36C, a novel amino acid substitution conferring hepatitis C virus (HCV) resistance to telaprevir, a potent peptidomimetic inhibitor of HCV protease

scientific article

Chronic hepatitis B: antiviral treatment guidelines

scientific article published on June 2010

Complex dynamics of hepatitis B virus resistance to adefovir

scientific article

DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4.

scientific article published on 12 February 2014

Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders

scientific article

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

scientific article published on 18 June 2012

Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis

scientific article published in May 2015

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

scientific article published on 30 July 2014

Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection

scientific article

Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection

scientific article published on 07 October 2015

Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.

scientific article

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.

scientific article published on 28 November 2007

Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals

scientific article published on 30 August 2011

Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring

scientific article published on 2 September 2015

Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay

scientific article

Dynamics of hepatitis B virus resistance to lamivudine

scientific article published on January 2006

Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study

scientific article published on 27 January 2015

Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin

scientific article published on 24 July 2006

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France

scientific article published on 28 January 2016

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis

scientific article published on 3 April 2014

Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study

scientific article published in August 2002

Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial

scientific article published on 4 August 2013

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis

scientific article published on 10 July 2015

Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily

scientific article published on 9 February 2007

Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection

scientific article published on 30 October 2013

Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study

scientific article

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

scientific article published on 20 November 2017

HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).

scientific article published on 3 July 2007

Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).

scientific article published on 28 March 2017

Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis

scientific article published on 22 January 2002

High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial).

scientific article

How to optimize HCV therapy in genotype 1 patients with cirrhosis

scientific article

Ideal oral combinations to eradicate HCV: The role of ribavirin

scientific article published on 24 September 2015

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study

scientific article published on 15 December 2015

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

scientific article published in December 2009

Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 Haplotype

scientific article published on 01 April 2011

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.

scientific article published in August 2005

Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy

scientific article published on 04 September 2019

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).

scientific article published on 13 March 2015

Long-Term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus–Associated Cryoglobulinemia Vasculitis

Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely

scientific article

Management of anaemia and other treatment complications

scientific article published on September 2013

Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies

scientific article

Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis

scientific article

New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor

scientific article published on October 2014

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

scientific article published on 31 March 2015

Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial

scientific article published on 16 June 2016

Oral combination therapy: future hepatitis C virus treatment? ⬇️

scientific article published on May 19, 2011

Patient with decompensated hepatitis C virus-related cirrhosis delisted for liver transplantation after successful sofosbuvir-based treatment

scientific article published on 20 January 2015

Performance of rapid diagnostic tests for the detection of anti-HBs in various patient populations

scientific article published on 28 September 2017

Performance of version 2.0 of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification

scientific article

Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy

scientific article published on 23 January 2015

Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4).

scientific article published on 27 August 2015

Randomized study of asunaprevir plus pegylated interferon-α and ribavirin for previously untreated genotype 1 chronic hepatitis C.

scientific article published on 26 June 2013

Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders

scientific article published on 26 October 2013

Resistance Analysis in Patients with Genotype 1-6 HCV Infection Treated with Sofosbuvir/Velpatasvir in the Phase 3 Studies

scientific article published on 5 December 2017

Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir-containing regimen

scientific article

Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE.

scientific article published on 25 October 2017

Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis

scientific article published on 10 February 2017

Simeprevir and daclatasvir for 12 or 24 weeks in treatment-naïve patients with hepatitis C virus genotype 1b and advanced liver disease

scientific article published on 30 January 2017

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

scientific article

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

scientific article published on 4 May 2014

Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.

scientific article

Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections

scientific article published on 31 May 2011

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

scientific article published on April 2009

Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.

scientific article published on 4 December 2013

The New Aptima HBV Quant Real-Time TMA Assay Accurately Quantifies Hepatitis B Virus DNA from Genotypes A to F.

scientific article published on 15 February 2017

The New Aptima HCV Quant Dx Real-time TMA Assay Accurately Quantifies Hepatitis C Virus Genotype 1-6 RNA.

scientific article published on 29 March 2017

Treatment of hepatitis C: Results in real life

scientific article published in February 2018

Treatment of patients with chronic hepatitis C who never had been treated

scientific article published in April 2002

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

scientific article published on 10 May 2013

Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients

scientific article

Why I do not treat patients for mild disease

scientific article published on January 2016

Paulina is supported by:

About Paulina

Help